Brief: Biomx To Present Preclinical Results With Bx004 In Cystic Fibrosis At The 44Th European Cystic Fibrosis Conference

Biomx

09/06/2021 11:57

June 9 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX TO PRESENT PRECLINICAL RESULTS WITH BX004 IN CYSTIC
FIBROSIS AT THE 44TH EUROPEAN CYSTIC FIBROSIS CONFERENCE
    * BIOMX INC - LOOK FORWARD TO ADVANCING BX004 TO A PHASE
1B/2A
TRIAL WITH RESULTS FROM PART 1 EXPECTED IN Q1 OF 2022

Source text for Eikon:  ID:nBw23ZY3Ba 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))